Discussion of MRCTs an “urgent imperative”


The 7th Asian New Drug Development Conference, to be held in Tokyo, Japan from April 15 to 16, will provide a forum for discussion about how MRCT data should be used in new drug applications. Program Chair Dr. Kihito Takahashi, M.D., Ph.D., vice president, Japan Development and Medical Affairs Division, GlaxoSmithKline K.K., said: “As understanding has deepened through experience with these trials, it is an urgent imperative for industry, government and academia to come together to discuss and resolve outstanding issues, and make improvements in collaboration internationally to activate new drug development in Asia.” Find out more.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide